-
公开(公告)号:FR2868313A1
公开(公告)日:2005-10-07
申请号:FR0403359
申请日:2004-03-31
Applicant: SERVIER LAB , CENTRE NAT RECH SCIENT
Inventor: CASTEILLA LOUIS , PENICAUD LUC , BERTHELOT PASCAL , DACQUET CATHERINE , CAIGNARD DANIEL HENRI
IPC: A61K9/20 , A61K31/15 , A61K31/428 , A61P3/04
Abstract: Association contenant un dérivé favorisant les métabolismes lipidique et glucidique de l'organisme et un agent antioxydant.Médicaments.
-
公开(公告)号:BR0315801A
公开(公告)日:2005-09-20
申请号:BR0315801
申请日:2003-11-04
Applicant: SERVIER LAB
Inventor: RAULT SYLVAIN , LANCELOT JEAN-CHARLES , KOPP MARINA , CAIGNARD DANIEL HENRI , PFEIFFER BRUNO , RENARD PIERRE
IPC: A61P3/04 , A61P3/10 , A61P9/10 , A61P9/12 , A61P19/02 , A61P35/00 , C07D471/04 , A61K31/505
Abstract: Pyridopyrimidone derivatives (I), their enantiomers, diastereoisomers, tautomers, and their salts with acids and bases are new. Pyridopyrimidone derivatives of formula (I), their enantiomers, diastereoisomers, tautomers, and their salts with acids and bases are new. R1, R2 = H or alkyl; R3 = halogen, alkoxy, aryl (optionally substituted by 1-3 R33), or NR'1R'2; R'1, R'2 = H, alkyl, or R'1-N-R'2 is a heterocycle; R4 = H or NR''1R''2; R''1, R''2 = H or alkyl; R1+R2, R'1+R'2, R''1+R''2 = mono or bicyclic of 5 - 11 C heterocycle optionally containing a further 1 or 2 heteroatoms (O, N, S), optionally substituted by 1-3 alkyl groups; R33 = halogens, alkyl, alkoxy, polyhaloalkyl (containing 1 - 3 C atoms and 1 - 7 halogen atoms) and hydroxy; provided that: (1) alkyl and alkoxy groups have 1 - 8 C atoms, aryl is phenyl or naphthyl; and An Independent claim is also included for the preparation of (I).
-
公开(公告)号:BR0315800A
公开(公告)日:2005-09-20
申请号:BR0315800
申请日:2003-11-04
Applicant: SERVIER LAB
Inventor: RAULT SYLVAIN , LANCELOT JEAN-CHARLES , KOPP MARINA , CAIGNARD DANIEL HENRI , PFEIFFER BRUNO , RENARD PIERRE , BIZOT-ESPIARD JEAN-GUY
Abstract: Imidazopyridine derivatives (I) are new. Imidazopyridine derivatives of formula (I), their enantiomers, diastereoisomers, and their salts with acids and bases are new. R1 = H, halogen, alkyl, polyhaloalkyl, CN, NO2, hydroxycarbonyl, alkoxycarbonyl, aminocarbonyl, or dialkylaminocarbonyl; R2 = H, alkyl, aryl (optionally substituted), heteroaryl (optionally substituted) or a group of formula R20-C(X)-; R20 = alkyl, alkoxy, amino, alkylamino, dialkylamino, aryl (optionally substituted), or heteroaryl (optionally substituted); X = O, S, or NR21; R21, R3 = H or alkyl; n = 1-6; and N = pyrido ring with the N atom in the 1, 2, 3, or 4 positions. Alkyl and alkoxy groups have 1-6 C atoms, aryl is phenyl or naphthyl, polyhaloalkyl groups having 1-3 C atoms and 1-7 halogen atoms, heteroaryl groups may be mono or bicyclic of 5 - 11 ring atoms, at least one ring being aromatic, and having 2 or 3 heteroatoms (O, N, S) and may be substituted by 1-3 alkyl groups. Optional substituents on aryl groups may be 1 or 2 substituents selected from halogens, alkyl, alkoxy, polyhaloalkyl, hydroxy, CN, NO2, amino, alkylamino, dialkylamino, carboxyl, amido, and -COO-alkyl groups, and heteroaryl groups having a non-aromatic ring may be further substituted on this non-aromatic ring by oxo.
-
公开(公告)号:BR0314878A
公开(公告)日:2005-08-02
申请号:BR0314878
申请日:2003-10-17
Applicant: SERVIER LAB
Inventor: COUDERT GERARD , AYERBE NATHALIE , LEPIFRE FRANK , ROUTIER SYLVAIN , CAIGNARD DANIEL HENRI , RENARD PIERRE , HICKMAN JOHN , PIERRE ALAIN , LEONCE STEPHANE
IPC: A61P35/00 , C07D471/14 , C07D487/04 , C07D491/14 , C07D491/147 , C07D491/22 , C07D498/14 , C07D498/22 , A61K31/5365
Abstract: 1,4-benzodioxino(2,3-e)isoindole derivatives (I) are new. 1,4-benzodioxino(2,3-e)isoindole derivatives of formula (I) and their enantiomers, diastereoisomers, N-oxides and addition salts with acids and bases are new. A = atoms that complete groups of formula (a) or (b); W1 = atoms that complete a phenyl or pyridyl ring; Z' = H, halogen, 1-6C alkyl or alkoxy (both optionally substituted by aryl), nitro, cyano, hydroxy, aryl, or NR5R6; R5, R6 = H or 1-6C alkyl; R4 = H, 1-6C alkyl, aryl, aryl(1-6C)alkyl or COOR'5; R'5 = 1-6C alkyl, aryl or aryl(1-6C)alkyl; Y' = oxygen or methylene; R2 = H; and R3 = H, 1-6C alkyl, aryl, aryl(1-6C)alkyl or trifluoromethylsulfonyl; or R2+R3 = bond; R1 = H, 1-6C alkyl, aryl, aryl(1-6C)alkyl, or 1-6C alkylene, substituted by one or more of OR5 or NR5R6; Z1, Z2 = H or; Z1+Z2 = fused phenyl; and aryl = phenyl, naphthyl, di- or tetra-hydronaphthyl, indenyl or indanyl (all optionally substituted by one or more of halo, 1-6C (trihalo)alkyl or alkoxy, hydroxy, amino or mono- or di-1-6C alkylamino. Provided that if Z' is H, then R1 is not H. Independent claims are included for preparing (I).
-
公开(公告)号:FR2865474A1
公开(公告)日:2005-07-29
申请号:FR0400689
申请日:2004-01-26
Applicant: SERVIER LAB
Inventor: FRANCOTTE PIERRE , FRAIKIN PIERRE , DE TULLIO PASCAL , PIROTTE BERNARD , LESTAGE PIERRE , DANOBER LAURENCE , CAIGNARD DANIEL HENRI , RENARD PIERRE
IPC: A61K31/5415 , A61K31/549 , A61P9/10 , A61P25/00 , A61P25/08 , A61P25/14 , A61P25/16 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07B53/00 , C07D285/22 , C07D285/24 , A61P25/18
Abstract: 4-(Fluorinated alkyl or fluorinated cycloalkylalkyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide derivatives (I) are new. Benzothiadiazine derivatives of formula (I) (including optical isomers where appropriate) and their acid or base addition salts are new. R fmono- or polyfluoroalkyl or mono- or polyfluoro-cycloalkylalkyl; R 1H, alkylaminocarbonyl or alkyl (optionally substituted by one or more halo); R 2H, halo, cycloalkyl or alkyl (optionally substituted by one or more halo); R 3 - R 6H, halo, NO 2, CN, alkylsulfonyl, OH, alkoxy, alkyl (optionally substituted by one or more halo) or NH 2 (optionally substituted by 1 or 2 alkyl); Alkyl moieties have 1-6C and cycloalkyl moieties 3-7C; provided that R 3 = H when R 6 is other than H. Independent claims are also included for: (A) new benzothiadiazine derivatives of formula (VI); and (B) the preparation of (I). [Image] [Image] ACTIVITY : Nootropic; Tranquilizer; Antidepressant; Neuroprotective; Antiparkinsonian; Anticonvulsant; Neuroleptic. In object recognition tests in 17 month old rats, 7-chloro-4-(2-fluoroethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide (Ia) at oral doses of 0.1 mg/kg significant reduced age-associated loss of memory. MECHANISM OF ACTION : alpha -Amino-5-methyl-4-isoxazole-propionic acid (AMPA) receptor modulator. In tests in Xenopus ovocytes, (Ia) strongly potentiated the excitative effect of AMPA, showing EC2X and EC5X values of 6.7 mu M and 14.5 mu M respectively for increasing the AMPA-inducedionic current.
-
公开(公告)号:FR2854634B1
公开(公告)日:2005-07-08
申请号:FR0305448
申请日:2003-05-05
Applicant: SERVIER LAB
Inventor: GRAINDORGE EMMANUEL , FRANCOTTE PIERRE , BOVERIE STEPHANE , DE TULLIO PASCAL , PIROTTE BERNARD , LESTAGE PIERRE , DANOBER LAURENCE , RENARD PIERRE , CAIGNARD DANIEL HENRI
IPC: A61P25/18 , C07D513/04 , A61K31/549
Abstract: Compounds of formula (I): wherein: A represents thienyl, furyl, pyrrolyl, oxathiol, thiazole, isothiazole, oxazole or imidazole, represents a single bond or a double bond, R1 represents hydrogen, linear or branched (C1-C6)alkyl optionally substituted by one or more groups selected from halogen or (C1-C6)alkoxy-(C1-C6)alkyl, R2 represents hydrogen or linear or branched (C1-C6)alkyl group optionally substituted by one or more halogen, R3 represents hydrogen or a group selected from linear or branched (C1-C6)alkyl, CONHR' and SO2NHR' wherein R' represents linear or branched (C1-C6)alkyl, its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base. Medicinal products containing the same, which are useful as AMPA inhibitors.
-
公开(公告)号:FR2846656A1
公开(公告)日:2004-05-07
申请号:FR0213802
申请日:2002-11-05
Applicant: SERVIER LAB
Inventor: RAULT SYLVAIN , LANCELOT JEAN CHARLES , KOPP MARINA , CAIGNARD DANIEL HENRI , PFEIFFER BRUNO , RENARD PIERRE , BIZOT ESPIARD JEAN GUY
IPC: A61P3/04 , A61P3/06 , A61P3/10 , A61P9/10 , C07D471/04 , A61K31/437
Abstract: Imidazopyridine derivatives (I) are new. Imidazopyridine derivatives of formula (I), their enantiomers, diastereoisomers, and their salts with acids and bases are new. R1 = H, halogen, alkyl, polyhaloalkyl, CN, NO2, hydroxycarbonyl, alkoxycarbonyl, aminocarbonyl, or dialkylaminocarbonyl; R2 = H, alkyl, aryl (optionally substituted), heteroaryl (optionally substituted) or a group of formula R20-C(X)-; R20 = alkyl, alkoxy, amino, alkylamino, dialkylamino, aryl (optionally substituted), or heteroaryl (optionally substituted); X = O, S, or NR21; R21, R3 = H or alkyl; n = 1-6; and N = pyrido ring with the N atom in the 1, 2, 3, or 4 positions. Alkyl and alkoxy groups have 1-6 C atoms, aryl is phenyl or naphthyl, polyhaloalkyl groups having 1-3 C atoms and 1-7 halogen atoms, heteroaryl groups may be mono or bicyclic of 5 - 11 ring atoms, at least one ring being aromatic, and having 2 or 3 heteroatoms (O, N, S) and may be substituted by 1-3 alkyl groups. Optional substituents on aryl groups may be 1 or 2 substituents selected from halogens, alkyl, alkoxy, polyhaloalkyl, hydroxy, CN, NO2, amino, alkylamino, dialkylamino, carboxyl, amido, and -COO-alkyl groups, and heteroaryl groups having a non-aromatic ring may be further substituted on this non-aromatic ring by oxo.
-
公开(公告)号:FR2846328A1
公开(公告)日:2004-04-30
申请号:FR0213194
申请日:2002-10-23
Applicant: SERVIER LAB
Inventor: RAULT SYLVAIN , KOPP MARINA , LANCELOT JEAN CHARLES , LEMAITRE STEPHANE , CAIGNARD DANIEL HENRI , BIZOT ESPIARD JEAN GUY , RENARD PIERRE
IPC: A61K31/381 , A61K31/402 , A61K31/417 , A61K31/4178 , A61K31/44 , A61K31/4439 , A61P3/00 , A61P3/04 , A61P3/06 , A61P3/10 , A61P9/00 , A61P9/10 , C07D401/06 , C07D403/06 , C07D409/06 , A61K31/4025 , A61K31/4402
Abstract: Imidazoline derivatives (I), their enantiomers, diastereoisomers, tautomers, and salts with acids and bases, are new. Imidazoline derivatives of formula (I), their enantiomers, diastereoisomers, tautomers, and salts with acids and bases, are new: R1 = heteroaryl optionally substituted by T1; R2 = cycloalkyl optionally substituted by T1; T1 = halogen, alkyl, alkoxy, OH, CN, NO2, (di)(alkyl)amino, COOH, COO-alkyl or CONH2-C(O)Rd; Rd = OH, alkoxy or amino; R4 , R5 = H, halogen, (polyhalo)alkyl, R10-C(X)-R11-, R10-Y-C(X)-R11-, R11-Y-R11-, or R10-S-(O)n-R11-; R11 = a bond, alkylene, alkenylene or alkynylene; X = O, S, or NR12; R3, R10, R12 = H or alkyl; Y = O, S or (alkyl)amino; and n = 1 or 2. Alkyl, alkoxy and alkylene have 1-6C, alkenylene have 2-6C and 1-3 double bonds, alkynylene have 2-6C and 1-3 triple bonds, polyhaloalkyl have 1-3C and 1-7 halogens, heteroaryl has 5 - 11 members and is mono or bicyclic with at least one aromatic ring and with 1-3 heteroatoms selected from O, N and S and may be substituted by an oxo group on a non-aromatic part of the structure, cycloalkyl has 3-10C, is mono or bicyclic and may have 1 or 2 unsaturations. An Independent claim is also included for the preparation of (I).
-
公开(公告)号:BRPI0708586A2
公开(公告)日:2011-06-07
申请号:BRPI0708586
申请日:2007-03-05
Applicant: SERVIER LAB
Inventor: HURTEVENT AURELIE , L'HELGOUAL'CH JEAN-MARTIAL , CARATO PASCAL , LEBEGUE NICOLAS , LECLERC VERONIQUE , NAOUR MORGAN LE , BERTHELOT PASCAL , DACQUET CATHERINE , KTORZA ALAIN , CAIGNARD DANIEL HENRI
IPC: C07D277/68 , A61K31/428 , A61P3/04 , A61P3/06 , A61P3/10
Abstract: Compounds of formula (I): wherein: R1 represents a (C3-C8)cycloalkyl group, R2 represents a group of formula (II) as defined in the description, X represents an oxygen atom or an N-OR' group wherein R' represents a hydrogen atom, a linear or branched (C1-C6)alkyl group, an aryl group or an aryl-(C1-C6)alkyl group in which the alkyl moiety may be linear or branched. Medicinal products containing the same which are useful as hypoglycaemic and hypolipaemic agents.
-
公开(公告)号:FR2948368A1
公开(公告)日:2011-01-28
申请号:FR0903573
申请日:2009-07-21
Applicant: SERVIER LAB , UNIV NANTES
Inventor: BOTEZ LULIANA , LEBRETON JACQUES , LESTAGE PIERRE , LOUIS CAROLINE , MATHE MONIQUE , CAIGNARD DANIEL HENRI
IPC: C07D211/42 , A61K31/445 , A61P25/28
Abstract: Composés de formule (1) : dans laquelle : > R représente un atome d'hydrogène ou un groupement méthyle, > R représente un atome de brome, un atome de fluor ou un groupement trifluorométhyle, Médicaments.
-
-
-
-
-
-
-
-
-